Co-treatment of TRAIL and glipizide also decreased cell viability and significantly sensitized apoptosis in Calu-3, HCC-15 cells (Figures 1E, 1F, 1G and 1H). The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.